Ovarian Cancer Treatment During COVID-19
- The coronavirus outbreak has forced oncologists to rethink decisions towards treatment
- Some patients are being given chemotherapies if procedures aren’t urgent
- Debulking surgeries have been delayed for some patients in order to decrease risks of COVID-19 infections
According to Dr. Ronald Alvarez, a gynecologic oncologist at the Vanderbilt University Medical Center in Nashville, Tennessee, the ongoing coronavirus pandemic has caused oncologists to rethink decision making towards ovarian cancer treatment.
Read MoreHospital Protocols Changing Amid COVID-19
Determining when surgery should be done for ovarian cancer patients has become more difficult to decide amid the pandemic, seeing as there might be an increased risk of infection for patients, and also that in some communities hard hit by the virus, hospitals are restricting scheduled surgeries even if doctors feel they are necessary. As many surgeries are being delayed, patients are being advised to connect with their doctors through virtual check-ups, also known as telemedicine. Despite the obstacles, oncologists have reassured the SurvivorNet community that cancer care is still a priority amid the outbreak.
It’s important that patients discuss their own situation with their doctors to decide whether surgery is urgent or if telemedicine is the safest option for the time being.
Learn more about SurvivorNet's rigorous medical review process.
